Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Tg Therapeutics (TGTX)

Tg Therapeutics (TGTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
37.99 +1.02 (+2.76%) 04/22/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 38.61 +0.62 (+1.63%) 19:50 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
37.48
Day High
38.58
Open 37.62
Previous Close 36.97 36.97
Volume 1,303,000 1,303,000
Avg Vol 2,832,520 2,832,520
Stochastic %K 61.23% 61.23%
Weighted Alpha +138.88 +138.88
5-Day Change -0.42 (-1.09%) -0.42 (-1.09%)
52-Week Range 12.93 - 43.32 12.93 - 43.32
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,806,915
  • Shares Outstanding, K 157,071
  • Annual Sales, $ 329,000 K
  • Annual Income, $ 23,380 K
  • EBIT $ 42 M
  • EBITDA $ 37 M
  • 60-Month Beta 2.14
  • Price/Sales 18.29
  • Price/Cash Flow 319.43
  • Price/Book 26.83

Options Overview Details

View History
  • Implied Volatility 90.59% ( -2.37%)
  • Historical Volatility 54.25%
  • IV Percentile 87%
  • IV Rank 74.39%
  • IV High 118.30% on 08/05/24
  • IV Low 10.10% on 06/10/24
  • Put/Call Vol Ratio 1.44
  • Today's Volume 3,786
  • Volume Avg (30-Day) 3,779
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 95,320
  • Open Int (30-Day) 98,210

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.19
  • Number of Estimates 6
  • High Estimate 0.28
  • Low Estimate 0.14
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +371.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.00 +22.55%
on 04/09/25
Period Open: 42.99
43.32 -12.30%
on 03/24/25
-5.00 (-11.63%)
since 03/21/25
3-Month
28.17 +34.86%
on 02/28/25
Period Open: 29.14
43.32 -12.30%
on 03/24/25
+8.85 (+30.37%)
since 01/22/25
52-Week
12.93 +193.81%
on 04/30/24
Period Open: 14.10
43.32 -12.30%
on 03/24/25
+23.89 (+169.43%)
since 04/22/24

Most Recent Stories

More News
TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why

Shares of TG Therapeutics, Inc. TGTX have rallied 29.5% in the past three months against the industry’s decline of 11.2%.The company’s sole marketed drug Briumvi (ublituximab-xiiy) was approved by...

TGTX : 37.99 (+2.76%)
KRYS : 168.80 (+4.26%)
DTIL : 5.32 (+3.70%)
JAZZ : 103.38 (+3.03%)
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TGTX : 37.99 (+2.76%)
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TGTX : 37.99 (+2.76%)
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

TGTX : 37.99 (+2.76%)
10 Best Stocks to Invest In Right Now

The U.S. stock market is experiencing a dramatic shift and volatility thanks to a cocktail of economic policies, industry-specific downturns, and shifting investor sentiment. These macroeconomic factors...

TGTX : 37.99 (+2.76%)
PYPL : 61.42 (+1.88%)
NVDA : 98.89 (+2.04%)
AVGO : 169.58 (+2.03%)
TSLA : 237.97 (+4.60%)
AMD : 86.26 (+0.82%)
ICE : 160.68 (+3.64%)
HEI : 240.98 (+1.57%)
AMZN : 173.18 (+3.50%)
BRO : 117.56 (+3.65%)
Why TG Therapeutics Stock Was Soaring This Week

Following news of an estimates-topping fourth quarter, TG Therapeutics (NASDAQ: TGTX) stock was a hot item with investors over the past few days. According to data compiled by S&P Global Market Intelligence,...

TGTX : 37.99 (+2.76%)
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TGTX : 37.99 (+2.76%)
Company News for Mar 4, 2025

California Resources Corp.’s (CRC) shares plummeted 11.7% after posting fourth-quarter 2024 adjusted earnings per share of $0.91, missing the Zacks Consensus Estimate of $0.34.Shares of TG Therapeutics...

TGTX : 37.99 (+2.76%)
BHVN : 21.15 (+2.92%)
CRC : 34.99 (+1.95%)
NOMD : 19.66 (+0.05%)
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week

Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year.

TGTX : 37.99 (+2.76%)
IJR : 96.66 (+2.42%)
VTI : 259.03 (+2.55%)
XBI : 77.64 (+2.82%)
TG Therapeutics: Q4 Earnings Snapshot

TG Therapeutics: Q4 Earnings Snapshot

TGTX : 37.99 (+2.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various...

See More

Key Turning Points

3rd Resistance Point 39.65
2nd Resistance Point 39.12
1st Resistance Point 38.55
Last Price 37.99
1st Support Level 37.45
2nd Support Level 36.92
3rd Support Level 36.35

See More

52-Week High 43.32
Last Price 37.99
Fibonacci 61.8% 31.71
Fibonacci 50% 28.13
Fibonacci 38.2% 24.54
52-Week Low 12.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro